BioLife Solutions Stock Price, News & Analysis (NASDAQ:BLFS)

$5.28 -0.05 (-0.94 %)
(As of 02/20/2018 04:00 PM ET)
Previous Close$5.28
Today's Range$5.25 - $5.42
52-Week Range$1.91 - $7.53
Volume15,538 shs
Average Volume60,892 shs
Market Capitalization$71.97 million
P/E Ratio-12.57
Dividend YieldN/A
Beta0.32

About BioLife Solutions (NASDAQ:BLFS)

BioLife Solutions logoBioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.

Receive BLFS News and Ratings via Email

Sign-up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:BLFS
CUSIPN/A
Phone+1-425-4011400

Debt

Debt-to-Equity RatioN/A
Current Ratio5.89%
Quick Ratio4.17%

Price-To-Earnings

Trailing P/E Ratio-12.5714285714286
Forward P/E Ratio-25.14
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.23 million
Price / Sales8.99
Cash FlowN/A
Price / CashN/A
Book Value$0.25 per share
Price / Book21.12

Profitability

Trailing EPS($0.42)
Net Income$-6,870,000.00
Net Margins-52.10%
Return on Equity-49.92%
Return on Assets-29.47%

Miscellaneous

Employees36
Outstanding Shares14,020,000

BioLife Solutions (NASDAQ:BLFS) Frequently Asked Questions

What is BioLife Solutions' stock symbol?

BioLife Solutions trades on the NASDAQ under the ticker symbol "BLFS."

How were BioLife Solutions' earnings last quarter?

BioLife Solutions Inc (NASDAQ:BLFS) released its earnings results on Thursday, November, 9th. The medical equipment provider reported ($0.03) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.06) by $0.03. The medical equipment provider earned $2.96 million during the quarter, compared to analysts' expectations of $2.60 million. BioLife Solutions had a negative return on equity of 49.92% and a negative net margin of 52.10%. View BioLife Solutions' Earnings History.

When will BioLife Solutions make its next earnings announcement?

BioLife Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, May, 9th 2018. View Earnings Estimates for BioLife Solutions.

Where is BioLife Solutions' stock going? Where will BioLife Solutions' stock price be in 2018?

2 Wall Street analysts have issued 12 month price targets for BioLife Solutions' stock. Their predictions range from $5.00 to $8.00. On average, they anticipate BioLife Solutions' stock price to reach $6.50 in the next year. View Analyst Ratings for BioLife Solutions.

Who are some of BioLife Solutions' key competitors?

Who are BioLife Solutions' key executives?

BioLife Solutions' management team includes the folowing people:

  • Raymond Wayne Cohen, Independent Chairman of the Board (Age 58)
  • Michael Rice, President, Chief Executive Officer, Chief Accounting Officer, Director (Age 53)
  • Roderick de Greef, Chief Financial Officer, Secretary (Age 56)
  • Aby J. Mathew Ph.D., Senior Vice President, Chief Technology Officer (Age 44)
  • Karen A Foster, Vice President - Operations
  • James Mathers, Vice President of Sales
  • Todd Berard, Vice President - Marketing (Age 47)
  • Thomas Girschweiler, Independent Director (Age 58)
  • Andrew G. Hinson, Independent Director (Age 53)
  • Joseph Schick, Independent Director (Age 54)

Who owns BioLife Solutions stock?

BioLife Solutions' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Essex Investment Management Co. LLC (1.81%), Millennium Management LLC (1.30%), Deutsche Bank AG (0.27%), Renaissance Technologies LLC (0.27%) and Wells Fargo & Company MN (0.13%). View Institutional Ownership Trends for BioLife Solutions.

Who sold BioLife Solutions stock? Who is selling BioLife Solutions stock?

BioLife Solutions' stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Deutsche Bank AG. View Insider Buying and Selling for BioLife Solutions.

Who bought BioLife Solutions stock? Who is buying BioLife Solutions stock?

BioLife Solutions' stock was acquired by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Millennium Management LLC and Wells Fargo & Company MN. View Insider Buying and Selling for BioLife Solutions.

How do I buy BioLife Solutions stock?

Shares of BioLife Solutions can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioLife Solutions' stock price today?

One share of BioLife Solutions stock can currently be purchased for approximately $5.28.

How big of a company is BioLife Solutions?

BioLife Solutions has a market capitalization of $71.97 million and generates $8.23 million in revenue each year. The medical equipment provider earns $-6,870,000.00 in net income (profit) each year or ($0.42) on an earnings per share basis. BioLife Solutions employs 36 workers across the globe.

How can I contact BioLife Solutions?

BioLife Solutions' mailing address is 3303 Monte Villa Pkwy Ste 310, BOTHELL, WA 98021-6200, United States. The medical equipment provider can be reached via phone at +1-425-4011400 or via email at [email protected]


MarketBeat Community Rating for BioLife Solutions (BLFS)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  145
MarketBeat's community ratings are surveys of what our community members think about BioLife Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BioLife Solutions (NASDAQ:BLFS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.50$6.50$6.50$5.50
Price Target Upside: 11.11% upside11.11% upside26.21% upside52.78% upside

BioLife Solutions (NASDAQ:BLFS) Consensus Price Target History

Price Target History for BioLife Solutions (NASDAQ:BLFS)

BioLife Solutions (NASDAQ:BLFS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/4/2018Maxim GroupSet Price TargetBuy$8.00HighView Rating Details
7/5/2017Janney Montgomery ScottUpgradeNeutral -> Buy$2.62 -> $5.00HighView Rating Details
(Data available from 2/20/2016 forward)

Earnings

BioLife Solutions (NASDAQ:BLFS) Earnings History and Estimates Chart

Earnings by Quarter for BioLife Solutions (NASDAQ:BLFS)

BioLife Solutions (NASDAQ BLFS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2018N/AView Earnings Details
11/9/2017Q3 2017($0.06)($0.03)$2.60 million$2.96 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.06)($0.06)$2.40 million$2.56 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.05)($0.07)$2.10 million$2.37 millionViewN/AView Earnings Details
3/9/2017Q4 2016($0.07)($0.04)$2.20 million$2.25 millionViewListenView Earnings Details
11/10/2016Q316($0.08)($0.08)$2.20 million$2.10 millionViewN/AView Earnings Details
8/11/2016Q216($0.09)($0.11)$2.01 million$2.00 millionViewListenView Earnings Details
5/12/2016Q1($0.08)($0.10)$2.20 million$1.85 millionViewListenView Earnings Details
2/25/2016Q415($0.11)($0.09)$1.66 million$1.82 millionViewListenView Earnings Details
11/12/2015Q315($0.10)($0.09)$1.67 million$1.60 millionViewN/AView Earnings Details
8/6/2015Q215($0.10)($0.08)$1.60 million$1.50 millionViewN/AView Earnings Details
5/7/2015Q1 2015($0.09)($0.09)$1.47 million$1.50 millionViewN/AView Earnings Details
3/12/2015Q4 2014($0.08)($0.08)$1.76 million$1.67 millionViewN/AView Earnings Details
11/6/2014Q3 2014($0.07)($0.07)$1.24 million$1.24 millionViewN/AView Earnings Details
8/7/2014Q2 2014($0.05)($0.07)$1.30 million$1.21 millionViewListenView Earnings Details
5/8/2014Q1 2014$0.01($0.10)$2.33 million$2.07 millionViewN/AView Earnings Details
2/12/2014Q4 2013($0.07)($0.10)$2.34 million$2.29 millionViewN/AView Earnings Details
4/1/2013Q4 2012($0.14)ViewN/AView Earnings Details
11/13/2012Q3 2012($0.14)($0.14)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.14)($0.10)ViewN/AView Earnings Details
5/14/2012Q1 2012($0.06)ViewN/AView Earnings Details
3/26/2012Q4 2011($0.08)ViewN/AView Earnings Details
11/14/2011Q3 2011($0.10)ViewN/AView Earnings Details
8/12/2011Q2 2011($0.08)ViewN/AView Earnings Details
5/16/2011Q1 2011($0.13)ViewN/AView Earnings Details
11/10/2008Q3 2008($0.14)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

BioLife Solutions (NASDAQ:BLFS) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.21 EPS
Next Year EPS Consensus Estimate: $-0.1 EPS

Dividends

Dividend History for BioLife Solutions (NASDAQ:BLFS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

BioLife Solutions (NASDAQ BLFS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 36.80%
Institutional Ownership Percentage: 10.14%
Insider Trades by Quarter for BioLife Solutions (NASDAQ:BLFS)
Institutional Ownership by Quarter for BioLife Solutions (NASDAQ:BLFS)

BioLife Solutions (NASDAQ BLFS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/15/2018Michael RiceCEOSell12,540$5.26$65,960.40152,057View SEC Filing  
1/16/2018Michael RiceCEOSell12,540$5.57$69,847.80152,057View SEC Filing  
8/8/2014Raymond W CohenChairmanBuy1,250$2.48$3,100.00View SEC Filing  
5/20/2014Raymond W CohenChairmanBuy4,000$2.39$9,560.00View SEC Filing  
5/14/2014Aby J MathewCTOBuy8,600$2.33$20,038.00View SEC Filing  
5/14/2014Michael RiceCEOBuy8,000$2.56$20,480.00View SEC Filing  
5/13/2014Michael RiceCEOBuy12,767$2.26$28,853.42View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

BioLife Solutions (NASDAQ BLFS) News Headlines

Source:
DateHeadline
Michael Rice Sells 12,540 Shares of BioLife Solutions Inc (BLFS) StockMichael Rice Sells 12,540 Shares of BioLife Solutions Inc (BLFS) Stock
www.americanbankingnews.com - February 16 at 10:20 PM
BioLife Solutions Executes OEM Agreement with MilliporeSigmaBioLife Solutions Executes OEM Agreement with MilliporeSigma
finance.yahoo.com - February 13 at 9:24 AM
BioLife Solutions Announces SAVSU Alliance with World CourierBioLife Solutions Announces SAVSU Alliance with World Courier
finance.yahoo.com - January 23 at 3:56 PM
SAVSU Technologies and BioLife Solutions Increase evo® Intellectual Property Estate with Notice of Allowance of New Patent for Cold Chain TechnologiesSAVSU Technologies and BioLife Solutions Increase evo® Intellectual Property Estate with Notice of Allowance of New Patent for Cold Chain Technologies
finance.yahoo.com - January 18 at 10:51 AM
Insider Selling: BioLife Solutions Inc (BLFS) CEO Sells 12,540 Shares of StockInsider Selling: BioLife Solutions Inc (BLFS) CEO Sells 12,540 Shares of Stock
www.americanbankingnews.com - January 17 at 7:34 PM
BioLife Solutions to Attend and Present at Upcoming Investor & Scientific ConferencesBioLife Solutions to Attend and Present at Upcoming Investor & Scientific Conferences
finance.yahoo.com - January 16 at 9:56 AM
Is There An Opportunity With BioLife Solutions Inc’s (NASDAQ:BLFS) 21.60% Undervaluation?Is There An Opportunity With BioLife Solutions Inc’s (NASDAQ:BLFS) 21.60% Undervaluation?
finance.yahoo.com - January 4 at 4:58 PM
Maxim Group Analysts Give BioLife Solutions (BLFS) a $8.00 Price TargetMaxim Group Analysts Give BioLife Solutions (BLFS) a $8.00 Price Target
www.americanbankingnews.com - January 4 at 3:38 PM
BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 6:37 PM
Shire (SHPG) vs. BioLife Solutions (BLFS) Head to Head ReviewShire (SHPG) vs. BioLife Solutions (BLFS) Head to Head Review
www.americanbankingnews.com - December 23 at 9:20 PM
Analyzing BioLife Solutions (BLFS) & Adamis Pharmaceuticals (ADMP)Analyzing BioLife Solutions (BLFS) & Adamis Pharmaceuticals (ADMP)
www.americanbankingnews.com - December 15 at 3:30 PM
Should BioLife Solutions Inc’s (undefined:BLFS) Earnings Decline In Recent Times Worry You?Should BioLife Solutions Inc’s (undefined:BLFS) Earnings Decline In Recent Times Worry You?
finance.yahoo.com - December 13 at 10:16 AM
The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDxThe Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx
finance.yahoo.com - December 1 at 5:15 PM
BioLife Solutions (BLFS) Buy Rating Reaffirmed at Maxim GroupBioLife Solutions' (BLFS) Buy Rating Reaffirmed at Maxim Group
www.americanbankingnews.com - November 30 at 12:42 PM
BioLife Solutions Executes Additional Long-Term Supply Agreement with Leading T Cell Therapy CustomerBioLife Solutions Executes Additional Long-Term Supply Agreement with Leading T Cell Therapy Customer
finance.yahoo.com - November 29 at 10:03 AM
Zacks.com featured highlights: H&E Equipment Services, Nomad Foods, Strayer Education, BioLife Solutions and Assembly BiosciencesZacks.com featured highlights: H&E Equipment Services, Nomad Foods, Strayer Education, BioLife Solutions and Assembly Biosciences
finance.yahoo.com - November 28 at 8:02 AM
Head to Head Review: XenoPort (XNPT) and BioLife Solutions (BLFS)Head to Head Review: XenoPort (XNPT) and BioLife Solutions (BLFS)
www.americanbankingnews.com - November 24 at 9:10 PM
Brokerages Expect BioLife Solutions, Inc. (BLFS) to Post ($0.07) Earnings Per ShareBrokerages Expect BioLife Solutions, Inc. (BLFS) to Post ($0.07) Earnings Per Share
www.americanbankingnews.com - November 14 at 9:46 AM
Edited Transcript of BLFS earnings conference call or presentation 9-Nov-17 9:30pm GMTEdited Transcript of BLFS earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 14 at 12:49 AM
Short Interest in BioLife Solutions, Inc. (BLFS) Expands By 44.7%Short Interest in BioLife Solutions, Inc. (BLFS) Expands By 44.7%
www.americanbankingnews.com - November 13 at 2:32 AM
BioLife Solutions, Inc. (BLFS) Price Target Raised to $8.00BioLife Solutions, Inc. (BLFS) Price Target Raised to $8.00
www.americanbankingnews.com - November 12 at 12:29 PM
BioLife Solutions, Inc. (BLFS) Announces Quarterly  Earnings ResultsBioLife Solutions, Inc. (BLFS) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 10 at 12:51 PM
BioLife Solutions Announces Third Quarter 2017 Financial ResultsBioLife Solutions Announces Third Quarter 2017 Financial Results
finance.yahoo.com - November 9 at 5:48 PM
ETFs with exposure to BioLife Solutions, Inc. : November 6, 2017ETFs with exposure to BioLife Solutions, Inc. : November 6, 2017
finance.yahoo.com - November 6 at 5:40 PM
BioLife Solutions to Report Third Quarter 2017 Financial Results and Provide Business Update on November 9, 2017BioLife Solutions to Report Third Quarter 2017 Financial Results and Provide Business Update on November 9, 2017
finance.yahoo.com - November 2 at 5:15 PM
BioLife Solutions, Inc. (BLFS) to Release Quarterly Earnings on WednesdayBioLife Solutions, Inc. (BLFS) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - November 1 at 4:06 AM
BioLife Solutions and SAVSU Providing Enhanced Cold Chain Technologies for 8 UCSF Clinical Trials of Treg Cell TherapiesBioLife Solutions and SAVSU Providing Enhanced Cold Chain Technologies for 8 UCSF Clinical Trials of Treg Cell Therapies
finance.yahoo.com - October 31 at 5:42 PM
Biolife Solutions Reaches Analyst Target PriceBiolife Solutions Reaches Analyst Target Price
www.thestreet.com - October 30 at 10:39 PM
BioLife Solutions Receives $1.9 Million from Exercise of WarrantsBioLife Solutions Receives $1.9 Million from Exercise of Warrants
finance.yahoo.com - October 30 at 5:38 PM
Contrasting BioLife Solutions (BLFS) & Theravance Biopharma (TBPHV)Contrasting BioLife Solutions (BLFS) & Theravance Biopharma (TBPHV)
www.americanbankingnews.com - October 28 at 1:28 PM
Maxim Group Reaffirms Buy Rating for BioLife Solutions, Inc. (BLFS)Maxim Group Reaffirms Buy Rating for BioLife Solutions, Inc. (BLFS)
www.americanbankingnews.com - October 26 at 8:34 AM
ETFs with exposure to BioLife Solutions, Inc. : October 23, 2017ETFs with exposure to BioLife Solutions, Inc. : October 23, 2017
finance.yahoo.com - October 23 at 5:29 PM
BioLife Solutions Customer Kite Pharma Receives FDA Approval for Yescarta™ (Axicabtagene Ciloleucel) CAR T-Cell TherapyBioLife Solutions Customer Kite Pharma Receives FDA Approval for Yescarta™ (Axicabtagene Ciloleucel) CAR T-Cell Therapy
finance.yahoo.com - October 19 at 5:08 PM
BioLife Solutions, Inc. (BLFS) PT Set at $7.00 by Maxim GroupBioLife Solutions, Inc. (BLFS) PT Set at $7.00 by Maxim Group
www.americanbankingnews.com - October 19 at 1:08 PM
BioLife Solutions to Present at Upcoming Investor ConferencesBioLife Solutions to Present at Upcoming Investor Conferences
finance.yahoo.com - October 18 at 5:54 PM
Should You Buy BioLife Solutions Inc (BLFS) Now?Should You Buy BioLife Solutions Inc (BLFS) Now?
finance.yahoo.com - October 18 at 5:53 PM
BioLife Solutions (BLFS) versus The Competition Head-To-Head ReviewBioLife Solutions (BLFS) versus The Competition Head-To-Head Review
www.americanbankingnews.com - October 17 at 8:28 PM
Reviewing BioLife Solutions (BLFS) & The CompetitionReviewing BioLife Solutions (BLFS) & The Competition
www.americanbankingnews.com - October 15 at 6:26 AM
ETFs with exposure to BioLife Solutions, Inc. : October 11, 2017ETFs with exposure to BioLife Solutions, Inc. : October 11, 2017
finance.yahoo.com - October 11 at 6:05 PM
Critical Analysis: BioLife Solutions (BLFS) & Its PeersCritical Analysis: BioLife Solutions (BLFS) & Its Peers
www.americanbankingnews.com - October 9 at 4:16 AM
BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017
finance.yahoo.com - October 2 at 1:00 PM
ETFs with exposure to BioLife Solutions, Inc. : September 28, 2017ETFs with exposure to BioLife Solutions, Inc. : September 28, 2017
finance.yahoo.com - October 2 at 1:00 PM
BLFS Crosses Above Average Analyst TargetBLFS Crosses Above Average Analyst Target
www.thestreet.com - September 19 at 9:38 PM
BioLife Solutions CryoStor® Cell Freeze Media Embedded in Cellular Biomedicine Group Clinical Trial of AlloJoin™BioLife Solutions CryoStor® Cell Freeze Media Embedded in Cellular Biomedicine Group Clinical Trial of AlloJoin™
finance.yahoo.com - September 19 at 4:37 PM
BioLife Solutions, Inc. (BLFS) Price Target Raised to $7.00BioLife Solutions, Inc. (BLFS) Price Target Raised to $7.00
www.americanbankingnews.com - September 19 at 3:52 PM
Lannett Co (LCI) and BioLife Solutions (BLFS) Financial ContrastLannett Co (LCI) and BioLife Solutions (BLFS) Financial Contrast
www.americanbankingnews.com - September 16 at 10:38 PM
BioLife Solutions to Present at September Investment ConferencesBioLife Solutions to Present at September Investment Conferences
finance.yahoo.com - September 7 at 4:50 PM
Novartis’ CAR-T therapy was the first approved in U.S. — here’s how to invest in the spaceNovartis’ CAR-T therapy was the first approved in U.S. — here’s how to invest in the space
finance.yahoo.com - August 31 at 4:27 PM
BioLife Solutions, Inc. (NASDAQ:BLFS) PT Set at $6.00 by Maxim GroupBioLife Solutions, Inc. (NASDAQ:BLFS) PT Set at $6.00 by Maxim Group
www.americanbankingnews.com - August 13 at 3:32 PM
Edited Transcript of BLFS earnings conference call or presentation 10-Aug-17 8:30pm GMTEdited Transcript of BLFS earnings conference call or presentation 10-Aug-17 8:30pm GMT
finance.yahoo.com - August 11 at 10:09 PM

SEC Filings

BioLife Solutions (NASDAQ:BLFS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

BioLife Solutions (NASDAQ:BLFS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

BioLife Solutions (NASDAQ BLFS) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.